IFNB1 and myeloid sarcoma: Hallal-longo et al. have explored the T cell response to myelin antigens and a nonspecific mitogen as well as the expression of CTLA-4 and Fas molecules in the PBMC of MS patients, either treated or untreated with IFN-β [87].